SY
Syra Health Corp. Class A Common Stock
SYRA · OTC
$0.86 -6.04% (-$0.06)
1M +10.26%
Market Cap $10.9M
P/E Ratio 83.10x
Div. Yield -
ROE 5.62%
Bulios Fair Price
$0.67
21.6% downside
Current Price
$0.86
Undervalued Fair Value Overvalued
According to Bulios Fair Price, SYRA is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
5/9Valuation
16 /100
Expensive EV/EBITDA 60.79x
P/S 1.34x
P/B 4.13x
Growth
70 /100
Growing Book val. growth 43.50%
Rev. growth 8.75%
FCF growth N/A
Profitability
25 /100
Weak Net margin 1.62%
Op. margin 0.92%
FCF margin 1.35%
Quality
32 /100
Poor ROE 5.62%
ROA 3.41%
Asset turnover 2.11x
Debt
100 /100
Low Current ratio 3.13x
Int. coverage 12.78x
Net debt/EBITDA -13.50x
Stability
10 /100
Unstable Rev. volatility 29.34%
EPS volatility 97.18%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SYRA
Online
Sector
Healthcare
Industry
Medical - Care Facilities
CEO
Gregory R. Alexander
Employees
89
Headquarters
Carmel
Upcoming events
18 NOV
Earnings
Upcoming earnings report